SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015State of the Art Treatment of HCV | Sanjay Bhagani, BSc FRCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Management of End-stage Liver Disease | Massimo Puoti, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Turkey | Cihan Yurdaydin, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Czech and Slovak Republics | Viktor Aster, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Baltic Countries | Saulius Caplinskas, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Romania | Adrian Streinu Cercel, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Ukraine | Larisa Moroz, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015AbbVieView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Local Situation in Poland | Milosz Parczewski, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Abstract: Evaluation of early cerebral alterations in the course of HIV and HCV infection using perfusion MR imaging: is the hepatitis C virus more dangerous for the brain? | J. Bladowska #8View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Abstract: Endothelial dysfunction and its influence on the development of subclinical atherosclerosis in HIV/HCV positive patients | K. Barska #10View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV 2015Abstract: Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1. | S. Mauss #6View Slideset
